Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Inventory (2016 - 2025)

Nutex Health's Inventory history spans 8 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 0.56% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $2.9 million, up 0.56%, while the annual FY2025 figure was $2.9 million, 0.56% up from the prior year.
  • Inventory for Q4 2025 was $2.9 million at Nutex Health, down from $3.2 million in the prior quarter.
  • Across five years, Inventory topped out at $3.5 million in Q4 2022 and bottomed at $2.3 million in Q3 2024.
  • The 5-year median for Inventory is $2.9 million (2022), against an average of $3.0 million.
  • The largest YoY upside for Inventory was 39.79% in 2025 against a maximum downside of 17.56% in 2025.
  • A 5-year view of Inventory shows it stood at $2.8 million in 2021, then increased by 25.55% to $3.5 million in 2022, then dropped by 4.04% to $3.4 million in 2023, then decreased by 15.94% to $2.8 million in 2024, then grew by 0.56% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Inventory are $2.9 million (Q4 2025), $3.2 million (Q3 2025), and $2.3 million (Q2 2025).